MD Anderson and Phoenix to advance cell and gene therapy tech
Phoenix will be supplied with rimiducid by MD Anderson as part of the cross-licensing agreement.

Phoenix will be supplied with rimiducid by MD Anderson as part of the cross-licensing agreement.
Trump has asked pharma companies to justify efficacy for their Covid-19 drugs as he attempts to quell unrest in his administration.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Oxford University and Ellison Institute link for AI vaccine research
FDA approves mRNA vaccines for new Covid-19 season amid political tension
AI psychosis sees users ‘co-creating delusions with technology’ – expert
Opadry complete film coating system: 45 years of trust, innovation and performance